Santosh Kumar Goru

590 total citations
15 papers, 415 citations indexed

About

Santosh Kumar Goru is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Santosh Kumar Goru has authored 15 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Santosh Kumar Goru's work include Renin-Angiotensin System Studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Epigenetics and DNA Methylation (2 papers). Santosh Kumar Goru is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Epigenetics and DNA Methylation (2 papers). Santosh Kumar Goru collaborates with scholars based in India, Canada and China. Santosh Kumar Goru's co-authors include Anil Bhanudas Gaikwad, Almesh Kadakol, Anuradha Pandey, Vajir Malek, Nisha Sharma, P. Shalem Raj, Darren A. Yuen, Xiaolin He, Stephen G. Szeto and Xiaolan Chen and has published in prestigious journals such as Scientific Reports, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Santosh Kumar Goru

15 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Santosh Kumar Goru India 13 210 81 75 63 63 15 415
Jia Guo China 14 233 1.1× 59 0.7× 115 1.5× 71 1.1× 61 1.0× 38 591
Himanshu Sankrityayan India 14 130 0.6× 45 0.6× 121 1.6× 38 0.6× 54 0.9× 20 410
Shanhong Lu China 13 254 1.2× 93 1.1× 60 0.8× 37 0.6× 67 1.1× 24 647
Adeel Ijaz United States 5 149 0.7× 59 0.7× 188 2.5× 37 0.6× 69 1.1× 8 459
Zhiyao Zhu China 11 432 2.1× 75 0.9× 198 2.6× 62 1.0× 36 0.6× 23 723
Dawei Zou China 10 404 1.9× 74 0.9× 206 2.7× 52 0.8× 33 0.5× 12 668
Zeyuan Lin China 12 258 1.2× 31 0.4× 78 1.0× 64 1.0× 36 0.6× 15 438
Wangqiu Gong China 12 366 1.7× 40 0.5× 120 1.6× 93 1.5× 32 0.5× 15 607
Darko Černe Slovenia 14 144 0.7× 83 1.0× 49 0.7× 40 0.6× 50 0.8× 35 427
Jingjing Wu China 14 309 1.5× 35 0.4× 23 0.3× 55 0.9× 63 1.0× 27 535

Countries citing papers authored by Santosh Kumar Goru

Since Specialization
Citations

This map shows the geographic impact of Santosh Kumar Goru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santosh Kumar Goru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santosh Kumar Goru more than expected).

Fields of papers citing papers by Santosh Kumar Goru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santosh Kumar Goru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santosh Kumar Goru. The network helps show where Santosh Kumar Goru may publish in the future.

Co-authorship network of co-authors of Santosh Kumar Goru

This figure shows the co-authorship network connecting the top 25 collaborators of Santosh Kumar Goru. A scholar is included among the top collaborators of Santosh Kumar Goru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santosh Kumar Goru. Santosh Kumar Goru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
He, Xiaolin, Santosh Kumar Goru, Luisa Ulloa Severino, et al.. (2022). Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis. JCI Insight. 7(4). 52 indexed citations
2.
He, Xiaolin, et al.. (2019). A new, easily generated mouse model of diabetic kidney fibrosis. Scientific Reports. 9(1). 12549–12549. 9 indexed citations
3.
Goru, Santosh Kumar, Almesh Kadakol, & Anil Bhanudas Gaikwad. (2017). Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy. Pharmacological Research. 120. 170–179. 25 indexed citations
4.
Kadakol, Almesh, Santosh Kumar Goru, Vajir Malek, & Anil Bhanudas Gaikwad. (2017). Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats. Biomedicine & Pharmacotherapy. 95. 1461–1468. 12 indexed citations
5.
Goru, Santosh Kumar, Almesh Kadakol, Vajir Malek, et al.. (2017). Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes. British Journal of Pharmacology. 174(18). 3118–3130. 65 indexed citations
6.
Pandey, Anuradha, P. Shalem Raj, Santosh Kumar Goru, et al.. (2017). Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacological Reports. 69(4). 666–672. 32 indexed citations
7.
Goru, Santosh Kumar & Anil Bhanudas Gaikwad. (2017). Novel reno-protective mechanism of Aspirin involves H2AK119 monoubiquitination and Set7 in preventing type 1 diabetic nephropathy. Pharmacological Reports. 70(3). 497–502. 12 indexed citations
8.
Kadakol, Almesh, Vajir Malek, Santosh Kumar Goru, et al.. (2017). Esculetin ameliorates insulin resistance and type 2 diabetic nephropathy through reversal of histone H3 acetylation and H2A lysine 119 monoubiquitination. Journal of Functional Foods. 35. 256–266. 19 indexed citations
9.
Goru, Santosh Kumar, Anuradha Pandey, & Anil Bhanudas Gaikwad. (2016). E3 ubiquitin ligases as novel targets for inflammatory diseases. Pharmacological Research. 106. 1–9. 30 indexed citations
10.
Pandey, Anuradha, Santosh Kumar Goru, Almesh Kadakol, et al.. (2016). H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats. Biochimie. 131. 68–76. 21 indexed citations
11.
Goru, Santosh Kumar, Almesh Kadakol, Anuradha Pandey, et al.. (2016). Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. Biochemical Journal. 473(21). 3937–3949. 37 indexed citations
12.
Kadakol, Almesh, et al.. (2015). Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochemical and Biophysical Research Communications. 461(2). 342–347. 34 indexed citations
13.
Kadakol, Almesh, Anuradha Pandey, Santosh Kumar Goru, Vajir Malek, & Anil Bhanudas Gaikwad. (2015). Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis. European Journal of Pharmacology. 765. 591–597. 13 indexed citations
14.
Pandey, Anuradha, Santosh Kumar Goru, Almesh Kadakol, Vajir Malek, & Anil Bhanudas Gaikwad. (2015). Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney. Biochimie. 118. 71–81. 28 indexed citations
15.
Kadakol, Almesh, Vajir Malek, Santosh Kumar Goru, Anuradha Pandey, & Anil Bhanudas Gaikwad. (2015). Esculetin reverses histone H2A/H2B ubiquitination, H3 dimethylation, acetylation and phosphorylation in preventing type 2 diabetic cardiomyopathy. Journal of Functional Foods. 17. 127–136. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia Guo Breakdown of academic impact, for papers by Himanshu Sankrityayan Breakdown of academic impact, for papers by Shanhong Lu Breakdown of academic impact, for papers by Adeel Ijaz Breakdown of academic impact, for papers by Zhiyao Zhu Breakdown of academic impact, for papers by Dawei Zou Breakdown of academic impact, for papers by Zeyuan Lin Breakdown of academic impact, for papers by Wangqiu Gong Breakdown of academic impact, for papers by Darko Černe Breakdown of academic impact, for papers by Jingjing Wu
Rankless by CCL
2026